-+ 0.00%
-+ 0.00%
-+ 0.00%

Camp4 Therapeutics announces annual shareholder meeting webcast

PUBT·04/23/2026 11:06:24
Listen to the news
Camp4 Therapeutics announces annual shareholder meeting webcast
  • Camp4 Therapeutics scheduled 2026 annual stockholder meeting for June 10, 2026 in virtual format.
  • Shareholders will vote on election of three Class II directors: Steven Holtzman, Murray Stewart, Richard Young.
  • Meeting agenda includes ratification of Ernst & Young as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Investors will also consider amendment to Camp4 2024 Equity Incentive Plan to include outstanding pre-funded warrants in evergreen share reserve calculation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001736730-26-000026), on April 23, 2026, and is solely responsible for the information contained therein.